Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APT-ANswer: Short- vs long-term dual antiplatelet therapy after flow diverter for cerebral aneurysm
jRCTs041230124Recruiting
- Sponsor
- Medtronic
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of aspirin, clopidogrel and prasugrel in brain aneurysm (IA) (2 arms), sponsored by Medtronic. Primary endpoint: Bleeding events during the first year after flow diverter treatment. Started Jan 2024; status: recruiting.
02
Drugs
aspirinclopidogrelprasugrel
03
Conditions
brain aneurysm (IA)
Beyond the preview
Go deeper on jRCTs041230124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041230124.